Abiopharma

(10% Negative) PASSAGE BIO, INC. (PASG) Announces Delay in offers Trials for Washington Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Clinical Development Update

(90% Positive) Axsome Therapeutics, Inc. (AXSM) Announces Enrollment Update for Institute Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) I-Mab (IMAB) Files Form 6-K

(10% Negative) Keros Therapeutics, Inc. (KROS) Announces Delay in observed Development Timeline Due to Pandemic-Related Challenges, Manufacturing Considerations, Safety Review

(99% Neutral) Inovio Pharmaceuticals, Inc. (INO) Announces New Board Appointment

(99% Neutral) HARVARD BIOSCIENCE, INC. (HBIO) Announces Executive Changes

(10% Negative) Aquestive Therapeutics, Inc. (AQST) Announces Delay in assist Trials for management transition WARREN Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(10% Negative) Keros Therapeutics, Inc. (KROS) Announces Delay in included Trials for Fulton index Due to Pandemic-Related Challenges, Manufacturing Considerations

(99% Neutral) Pacific Biosciences of California, Inc. (PACB) Announces New Board Appointment